Human HIV Vaccine Trial Begins With BRILLIANT 011

South Africa launches the HIV vaccine trial, BRILLIANT 01, testing a new vaccine cocktail designed to prime broadly neutralising antibodies.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Tagged BRILLIANT 011, Cape Town, clinical trials, Desmond Tutu HIV Foundation, global health, HIV, HIV Prevention, HIV Vaccine, lenacapavir, PrEP, SAMRC, South Africa